When to use a metaphor: metaphors in dialogical explanations with addressees of different expertise

Autor: Ingrid Scharlau, Miriam Körber, Meghdut Sengupta, Henning Wachsmuth

Publikováno v: Frontiers in Language Sciences, Vol 3 (2024)

The present study aims to understand how metaphors are used in explanations. According to many current theories, metaphors have a conceptual function for the understanding of abstract objects. From this theoretical assumption, we derived the hypothes

Externí odkaz: https://doaj.org/article/4ebd3f40a9984afeb157c3012d190070

Clinicohematologic and molecular response of essential thrombocythemia patients treated with pegylated interferon-α: a multi-center study of the German Study Group-Myeloproliferative Neoplasms (GSG-MPN)

Autor: Frank Stegelmann, Lino L. Teichmann, Florian H. Heidel, Carl C. Crodel, Thomas Ernst, Sebastian Kreil, Andreas Reiter, Sara Otten, Stefanie Schauer, Ruth-Miriam Körber, Kim Kricheldorf, Susanne Isfort, Hartmut Döhner, Tim H. Brümmendorf, Martin Griesshammer, Konstanze Döhner, Steffen Koschmieder

Publikováno v: Leukemia. 37:924-928

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2d6a0ebd791c5f49106f89080d4c2ae0
https://doi.org/10.1038/s41375-023-01837-9

Macrophage frequency in the bone marrow correlates with morphologic subtype of myeloproliferative neoplasm

Autor: Steffen Koschmieder, Gabor Horvath, Ines Gütgemann, Andreas Buness, Ruth-Miriam Körber, Lino L. Teichmann, Rebekka K. Schneider, David C A Molitor, Peter Boor

Publikováno v: Annals of Hematology
Annals of Hematology, 100(1), 97-104. Springer-Verlag
Annals of hematology 100(1), 97-104 (2021). doi:10.1007/s00277-020-04304-Y

Annals of hematology 100(1), 97-104 (2021). doi:10.1007/s00277-020-04304-Y
Published by Springer, Berlin ; Heidelberg ; New York

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4827aaac75c72651d796dfc28c6313c9
https://doi.org/10.1007/s00277-020-04304-y

Interferon Gamma (IFNγ) Interferes with the Effects of Tyrosine Kinase Inhibitors (TKI) In CML Cells

Autor: Grethe Kock, Nina Manon Seltmann, Stefanie Ae Held, Peter Brossart, Anita Bringmann, Ruth-Miriam Körber, Annkristin Heine

Publikováno v: Blood. 116:3393-3393

Abstract 3393 Introduction: Chronic myeloid leukemia (CML) is a myeloproliferative disease which resolves in the constitutive activity of the BCR-ABL protein. Since the introduction of imatinib as first line therapy for CML, the overall survival of p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a8a981824153b925d5cc6b30443f7a99
https://doi.org/10.1182/blood.v116.21.3393.3393